Core Insights - Agilent Technologies reported revenue of $1.86 billion for Q4 2025, exceeding revenue guidance and showing a growth of 9.4% reported and 7.2% core compared to Q4 2024 [1] - The company's GAAP net income for Q4 2025 was $434 million, or $1.53 per share, an increase from $351 million, or $1.22 per share, in Q4 2024 [1] - Non-GAAP net income for Q4 2025 was $452 million, or $1.59 per share [1]

Core Insights - Agilent Technologies reported fourth-quarter revenue that exceeded estimates, driven by robust demand for medical tools and equipment utilized in laboratory research and diagnostic services [1] Company Summary - Agilent Technologies is a life sciences firm that has shown strong performance in the fourth quarter, indicating a positive trend in revenue generation [1] - The company's success is attributed to the increasing need for medical tools and equipment, reflecting a growing market in lab research and diagnostics [1]

Core Insights - Agilent Technologies, Inc. is set to release its fourth-quarter earnings results on November 24, with analysts expecting earnings of $1.58 per share, an increase from $1.46 per share in the same period last year [1] - The consensus estimate for Agilent's quarterly revenue is $1.83 billion, compared to $1.7 billion in the previous year [1] - A cash dividend of 25.5 cents per share was announced by Agilent on November 19 [1] Stock Performance - Agilent's shares increased by 4.3%, closing at $151.25 on Friday [2] Analyst Ratings - TD Cowen analyst Dan Brennan maintained a Buy rating and raised the price target from $150 to $162 [4] - UBS analyst Dan Leonard upgraded the stock from Neutral to Buy and increased the price target from $130 to $170 [4] - Rothschild & Co. analyst Natalya Davies initiated coverage with a Buy rating and a price target of $165 [4] - Wells Fargo analyst Brandon Couillard maintained an Overweight rating and raised the price target from $140 to $150 [4] - Baird analyst Catherine Schulte maintained an Outperform rating and increased the price target from $141 to $142 [4]

Group 1 - Wall Street anticipates Zoom Communications Inc (NASDAQ:ZM) to report quarterly earnings of $1.44 per share on revenue of $1.21 billion [2] - Lee Enterprises, Inc. (NYSE:LEE) announced the resignation of CFO Tim Millage, effective February 28, 2026, with shares gaining 1.6% to close at $4.56 [2] - Keysight Technologies Inc (NYSE:KEYS) is expected to post quarterly earnings of $1.83 per share on revenue of $1.38 billion, with shares gaining 1.8% to close at $172.71 [2] - Wrap Technologies Inc (NASDAQ:WRAP) filed for a mixed shelf offering of up to $200 million, with shares gaining 6.6% to close at $2.11 [2] - Agilent Technologies Inc (NYSE:A) is expected to report quarterly earnings of $1.58 per share on revenue of $1.83 billion, with shares gaining 4.3% to close at $151.25 [2]

Market Sentiment - The CNN Money Fear and Greed index showed some easing in the overall fear level, remaining in the "Extreme Fear" zone with a current reading of 10.5, up from a prior reading of 7.2 [1][5]. Stock Market Performance - U.S. stocks settled higher on Friday, with the Dow Jones index gaining more than 1%, closing higher by around 493 points to 46,245.41. The S&P 500 gained 0.98% to 6,602.99, while the Nasdaq Composite gained 0.88% to 22,273.08 [1][4]. - Despite the gains on Friday, all three major indices recorded significant losses last week, with the S&P 500 and Dow falling around 2% each [2]. Company Earnings - Shares of Elastic N.V. (NYSE:ESTC) dipped 15% after posting second-quarter earnings. In contrast, BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) reported better-than-expected earnings for the third quarter [3]. - Investors are awaiting earnings results from Zoom Communications Inc (NASDAQ:ZM), Keysight Technologies Inc (NYSE:KEYS), and Agilent Technologies Inc (NYSE:A) [4]. Economic Indicators - The University of Michigan's consumer sentiment index increased to 51.0 in November from a preliminary reading of 50.3. The S&P Global composite PMI rose to 54.8 in November from 54.6 in October, exceeding market estimates of 54.5 [3].

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

In the current session, the stock is trading at $151.46, after a 4.41% increase. Over the past month, Agilent Technologies Inc. (NYSE:A) stock increased by 2.31%, and in the past year, by 12.61%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Evaluating Agilent Technologies P/E in Comparison to Its PeersThe P/E ratio measures the current share price to the company's EPS. It is used ...

Core Insights - Agilent Technologies is a key player in the life sciences, diagnostics, and applied chemical markets, known for its innovative solutions and products [1] - The company is set to release its quarterly earnings on November 24, 2025, with investors closely monitoring its financial performance [1] Financial Performance Expectations - Analysts project Agilent's earnings per share (EPS) to be $1.59, reflecting an 8.9% increase from the previous year [2] - Revenue is expected to reach $1.83 billion, marking a 7.8% rise from the same quarter last year, indicating successful market expansion strategies [2] Analyst Confidence - The stability in the consensus EPS estimate over the past 30 days suggests strong analyst confidence in Agilent's financial outlook [3] - Historical data indicates a strong link between earnings estimate revisions and stock price trends, making this stability a positive sign for the company [3] Financial Metrics - Agilent has a price-to-earnings (P/E) ratio of 33.89, indicating that investors are willing to pay a premium for its earnings [4] - The price-to-sales ratio is 6.06, and the enterprise value to sales ratio is 6.34, highlighting the company's market valuation relative to its sales and revenue [4] Financial Health Indicators - The debt-to-equity ratio stands at 0.54, reflecting a balanced approach to financing assets [5] - A current ratio of 2.25 suggests that Agilent is well-positioned to meet its short-term liabilities [5] - The earnings yield is 2.95%, providing a comprehensive view of the company's financial stability and growth potential [5]

Core Insights - Analysts project Agilent Technologies will report quarterly earnings of $1.59 per share, an increase of 8.9% year over year, with revenues expected to reach $1.83 billion, up 7.8% from the same quarter last year [1] Revenue Estimates - Net Revenue from the Life Sciences and Diagnostics Markets Segment is estimated at $728.07 million, reflecting a year-over-year decline of 12.6% [4] - Net Revenue from the Agilent Crosslab Group is projected to be $750.83 million, indicating a significant increase of 76.3% year over year [4] - Revenue from the Chemical and Advanced Materials end market is expected to reach $410.16 million, showing a growth of 6.5% from the prior-year quarter [5] - Revenue from the Environmental and Forensics end market is forecasted at $180.82 million, representing a 10.3% increase from the prior-year quarter [5] - Revenue from the Diagnostics and Clinical end market is estimated at $266.56 million, indicating a year-over-year growth of 4.5% [6] - Revenue from the Academia and Government end market is projected to be $158.45 million, reflecting a change of 5.6% from the prior-year quarter [6] - Revenue from the Pharmaceutical end market is expected to reach $645.74 million, indicating an increase of 8.5% from the prior-year quarter [7] - Revenue from the Food end market is projected at $164.74 million, reflecting an increase of 8.4% from the prior-year quarter [7] Market Performance - Agilent shares have shown a return of -1.3% over the past month, compared to a -0.6% change in the Zacks S&P 500 composite [7] - Agilent holds a Zacks Rank 3 (Hold), suggesting it is expected to mirror overall market performance in the near future [7]

Core Viewpoint - Agilent Technologies Inc. will participate in a fireside chat at Citi's 2025 Global Healthcare Conference, highlighting its engagement with investors and the healthcare sector [1] Group 1 - The event is scheduled for December 4, 2025, from 9 to 9:45 a.m. EDT in Miami, Florida [1] - Chief Enterprise Transformation Officer Tom Callihan and Head of Investor Relations Tejas Savant will represent the company during the discussion [1] - A live audio webcast and replay of the presentation will be accessible through Agilent's Investor Relations website [1]